P3 Health Partners Extends Promissory Note Maturity to 2028, Increases PIK Interest to 14%
PIII has more than doubled off its 52-week low of $1.52 on light trading volume (0.1× avg).
Summary
P3 Health Partners amended a promissory note, extending its maturity to September 2028 while increasing the non-cash PIK interest rate to 14%.
Key Events · Financing and Capital Events · PIII
-
Debt Maturity Extended
The maturity date of a Repurchase Promissory Note with IHC Health Services, Inc. has been extended from its previous term to September 30, 2028.
-
PIK Interest Rate Increased
The Payment-in-Kind (PIK) interest rate on the Note will increase from 11% to 14% per annum, effective June 30, 2026.
-
Material Definitive Agreement
The amendment constitutes a material definitive agreement, indicating its significance to the company's financial structure.
Analysis · PIII · Industrial Applications And Services
P3 Health Partners has amended a repurchase promissory note, extending its maturity date by over two years to September 30, 2028. This provides the company with additional financial flexibility and pushes out a debt obligation. However, the amendment also increases the payment-in-kind (PIK) interest rate from 11% to 14% per annum, meaning the debt will accrue at a higher non-cash rate. This follows recent efforts by the company to manage its debt and improve its financial position, including a significant debt exchange in April 2026 and achieving positive net income in Q1 2026.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 29.4% of the 1386 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PIII was trading at $10.29 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $74.6M. The 52-week trading range was $1.52 to $16.89. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.